Patents by Inventor Anca Remes

Anca Remes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NFAT binding polynucleotides
    Patent number: 11618773
    Abstract: The present invention relates to a polynucleotide comprising a Nuclear factor of activated T-cells (NFAT) binding site sequence and a reverse complement of said NFAT binding site sequence separated by a spacer sequence, to said polynucleotide for use in treating and/or preventing disease, and to viral particles, compositions, and uses related thereto. The present invention further relates to a polynucleotide comprising a Nuclear factor of activated T-cells (NFAT) binding site sequence and a reverse complement of said NFAT binding site sequence for use in treating and/or preventing an NFAT-mediated disease.
    Type: Grant
    Filed: January 14, 2019
    Date of Patent: April 4, 2023
    Assignee: Universität Heidelberg
    Inventors: Markus Hecker, Andreas Wagner, Andreas Jungmann, Oliver Müller, Anca Remes, Hugo Katus
  • COMPOUND DECREASING THE CONCENTRATION OF 2-HYDROXY-GLUTARATE
    Publication number: 20220111013
    Abstract: The present invention relates to a compound decreasing the concentration of 2-hydroxy-glutarate (2HG) in a subject for use in treating, preventing, and/or preventing progression of cardiac remodeling, in particular cardiomyopathy and/or heart failure and to viral particles, compositions, uses and methods related thereto.
    Type: Application
    Filed: January 23, 2020
    Publication date: April 14, 2022
    Applicants: Universität Heidelberg, Christian-Albrechts-Universitat zu Kiel
    Inventors: Oliver MÜLLER, Hugo KATUS, Norbert FREY, Lin DING, Andreas JUNGMANN, Anca REMES, Philipp SCHATZ, Beate KAMLAGE, Philipp TERNES
  • NFAT BINDING POLYNUCLEOTIDES
    Publication number: 20210070820
    Abstract: The present invention relates to a polynucleotide comprising a Nuclear factor of activated T-cells (NFAT) binding site sequence and a reverse complement of said NFAT binding site sequence separated by a spacer sequence, to said polynucleotide for use in treating and/or preventing disease, and to viral particles, compositions, and uses related thereto. The present invention further relates to a polynucleotide comprising a Nuclear factor of activated T-cells (NFAT) binding site sequence and a reverse complement of said NFAT binding site sequence for use in treating and/or preventing an NFAT-mediated disease.
    Type: Application
    Filed: January 14, 2019
    Publication date: March 11, 2021
    Inventors: Markus Hecker, Andreas Wagner, Andreas Jungmann, Oliver Müller, Anca Remes, Hugo Katus